Medtech Start-Up Financing Strategies: Where’s The Money?
This article was originally published in Start Up
Despite the dire headlines, VCs are still investing in medtech start-ups, although the deals are becoming fewer and later stage. Start-ups looking for funding have to be more creative and look beyond traditional sources of funding, according to a discussion by six European venture capitalists speaking at the IN3 meeting in Dublin in April 2013.
You may also be interested in...
With €12 billion under management, the European Investment Fund has made a significant imprint on Europe’s venture capital community. The EIF holds stakes in more than 260 venture capital funds in Europe and is invested in roughly 80% of the active European VC funds.
Why are European physicians so far ahead of the curve when it comes to innovative clinical practice and so far behind when it comes to creating companies? Interventional cardiologist and serial entrepreneur Martin Rothman offers some answers.
Elsevier’s Strategic Transactions shows that just in the last year, 26 spine or low back pain companies received private funding. To be sure, many were small rounds, some were funded with debt, and some were insider rounds trying to keep companies moving forward, but venture investors showed excitement by investing in large rounds for a select number of start-ups.